Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 385 followers
Latest posts
Last updated 39 minutes ago
Intercept, on heels of Ocaliva withdrawal, restructures with 146 layoffs
39 minutes ago
"Following the withdrawal of Ocaliva from the U.S. market, we are making...
With pivotal trial underway, Ionis ramps up Angelman syndrome awareness with Lifetime TV segment
about 3 hours ago
After spending the last decade developing the drug known as ION582 and...
Hansa falls short in bid to push EU-approved kidney transplant drug into new autoimmune indication
about 4 hours ago
Three months after reporting a win in a phase 3 trial of...
Keytruda, Padcev keep winning streak with another patient survival benefit in bladder cancer
about 5 hours ago
The PD-1/ADC combo showed an overall survival benefit as a perioperative treatment...
Alnylam lays out $250M to equip flagship facility with cutting-edge siRNA production tech
about 5 hours ago
Alnylam plans to spend $250 million in a bid to elevate its...
ImmunityBio, eyeing broader reach for Anktiva, flexes survival showing in bladder cancer subtype
about 6 hours ago
The data come from a cohort of patients with BCG-unresponsive non-muscle-invasive bladder...
GSK rounds out year of approvals with FDA asthma nod for long-acting biologic Exdensur
about 7 hours ago
Tuesday, the U.S. regulator greenlit GSK’s depemokimab, an ultra-long-acting biologic, as a...
Rising Stars: Lundbeck’s Andrew Willett is leaving the world a better place through pharma comms
about 9 hours ago
In a Q&A for Fierce Pharma Marketing’s “Rising Stars” series, Andrew Willett...
Fosun signs up to take on China's Green Valley, revive controversial Alzheimer's med
1 day ago
The Chinese drugmaker is taking on a 53% stake in Green Valley...
Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug
1 day ago
Vivek Ramaswamy has found time out of his campaign for governor of...
Avalere taps longtime Senate staffer to head up healthcare policy team amid regulatory turbulence
1 day ago
As biopharma and healthcare companies face a rapidly shifting regulatory environment, marketing...
Pfizer shares drop 5% with 2026 revenue projection and long-range outlook
1 day ago
With COVID sales falling and patent protections expiring, Pfizer is forecasting its...